Most patients with a cardiac resynchronisation therapy (CRT) pacemaker would not benefit from the addition of a defibrillator, according to results from the CeRtiTuDe cohort study presented for the ...

Please provide your email address to receive an email when new articles are posted on . Long-term CRT-D use was tied to improved survival and time to adverse events vs. ICD therapy in patients with ...

George H. Crossley, M.D.; Kazutaka Aonuma, M.D.; Charles Haffajee, M.D.; Morio Shoda, M.D.; Albert Meijer, M.D.; Alexander Bauer, M.D.; Alexander Bauer, M.D ...

In a large population of Medicare beneficiaries with heart failure who underwent implantation of a cardiac resynchronization therapy defibrillator, patients who had the cardiac characteristics of left ...

Please provide your email address to receive an email when new articles are posted on . Among patients with nonischemic cardiomyopathy, women were less likely to die or have a ventricular event than ...

The Food and Drug Administration approved Dublin-based Medtronic’s Claria MRI Quad Cardiac Resynchronization Therapy Defibrillator for patients with heart failure. The Claria MRI CRT-D contains ...

PLATINIUM, released simultaneously in both Europe and Japan by LivaNova (formerly Sorin Group), will protect patients from avoidable replacement surgeries and the inherent risk of complications.

SILVER SPRING, MD — Women, compared with men, showed improved survival from cardiac resynchronization therapy (CRT) across a wider range of prolonged QRS durations, a key factor in guidelines-based ...